Escitalopram treatment of kleptomania: an open-label trial followed by double-blind discontinuation.

@article{Koran2007EscitalopramTO,
  title={Escitalopram treatment of kleptomania: an open-label trial followed by double-blind discontinuation.},
  author={Lorrin Michael Koran and Elias N Aboujaoude and Nona N Gamel},
  journal={The Journal of clinical psychiatry},
  year={2007},
  volume={68 3},
  pages={422-7}
}
BACKGROUND Kleptomania has no definitive treatment. Mixed reports of benefit from openly prescribed selective serotonin reuptake inhibitors led us to design a double-blind, placebo-controlled discontinuation trial of escitalopram. METHOD Between December 2002 and March 2005, we recruited 24 subjects aged >or=20 years with DSM-IV kleptomania of >or=1 year's duration. We excluded subjects with organic mental disorders, psychoses, substance or alcohol abuse, suicidal risk, bipolar I or II… CONTINUE READING
9 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-9 of 9 extracted citations

Similar Papers

Loading similar papers…